After months of statements, speculation, trade talks, tweets and threats, the U.S. government has officially put tariffs in place on $50 billion worth of products imported from China, including medical imaging equipment. X-ray, CT and MRI equipment are all on the list of products included in this announcement.

A host of medical devices—including imaging equipment, pacemakers and electrocardiographs—are included in the list of Chinese products that will be hit with a 25 percent tariff beginning July 6, the U.S. government announced Friday.

After months of statements, speculation, trade talks, tweets and threats, the U.S. government has officially put tariffs in place on $50 billion worth of products imported from China, including medical imaging equipment. X-ray, CT and MRI equipment are all on the list of products included in this announcement.

In a Thursday, June 14, ruling, a federal appellate court denied claims from health insurers who claimed they were owed billions of dollars from an Affordable Care Act (ACA) program. The court ruled 2-1 against two insurers who wanted the federal government to repay them for covering sicker, more expensive patients than initially expected.

After multiple threats from President Donald Trump, the Office of the United States Trade Representatives (USTR) announced they will go-forward with 25 percent tariffs on approximately $50 billion worth of Chinese imports—including medical imaging equipment.

Evangelical Community Hospital in Lewisburg, Pennsylvania, recently poured $7 million into its Center for Orthopaedics, the Daily Item reported this week—and the radiology renovation is prioritizing patient flow when many imagers are struggling to keep up with an increasing demand for their work.

Nicole Dhanraj, PhD, chief of radiology at Guam Memorial Hospital in Tamuning, submitted a written testimony to the Legislature of Guam about issues she says she encountered while working at the hospital.

Individuals with high blood pressure are at an increased risk for developing dementia, according to an imaging study funded by the Italian government.